Search





Search





Markets
/
Stocks
/
nasdaq-fonr
/

Fonar Corp

FONR

Add to Watchlist

18.860USD

0.0000.00%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

138.07MMarket Cap

17.96P/E TTM



Fonar Corp

18.860

0.0000.00%

Overview Financials Discussions Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Fonar Corp

Currency: USD Updated: 2026-05-15

Key Insights

Fonar Corp's fundamentals are relatively very healthy, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 152 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Fonar Corp's Score

Industry at a Glance

Industry Ranking

152 / 206

Overall Ranking

425 / 4482

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Fonar Corp Highlights

StrengthsRisks

FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.

Overvalued

The company’s latest PE is 17.96, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 2.79M shares, decreasing 21.14% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 315.72K shares of this stock.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Fonar Corp is 7.36, ranking 75 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 26.47M, representing a year-over-year decrease of 2.55%, while its net profit experienced a year-over-year decrease of 30.08%.

Score

Industry at a Glance

Previous score

7.36

Change



Financials

9.50

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.43

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.88

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.86

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.12

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Fonar Corp's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Fonar Corp is 6.36, ranking 162 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 17.96, which is 0.00% below the recent high of 17.96 and 55.37% above the recent low of 8.02.

Score

Industry at a Glance

Previous score

6.36

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 152/206

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

No earnings forecast score is currently available for Fonar Corp. The Healthcare Equipment & Supplies industry's average is 7.80.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Fonar Corp is 4.87, ranking 182 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 18.95 and the support level at 18.78, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

4.85

Change

0.02

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.034

Neutral

RSI(14)

61.837

Neutral

STOCH(KDJ)(9,3,3)

34.108

Neutral

ATR(14)

0.034

High Vlolatility

CCI(14)

-62.431

Neutral

Williams %R

69.231

Sell

TRIX(12,20)

0.044

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

18.856

Buy

MA10

18.871

Sell

MA20

18.866

Sell

MA50

18.676

Buy

MA100

18.434

Buy

MA200

16.807

Buy

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Fonar Corp is 3.00, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 45.24%, representing a quarter-over-quarter decrease of 21.20%. The largest institutional shareholder is The Vanguard, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Money Concepts Capital Corp

510.67K

+5.62%

Shane (Hilary L)

413.21K

Renaissance Technologies LLC

Star Investors

315.72K

+2.30%

Dimensional Fund Advisors, L.P.

373.32K

-0.97%

Kayne Anderson Rudnick Investment Management, LLC

251.35K

-53.19%

Damadian (Timothy Raymond)

121.96K

+54.26%

Peapod Lane Capital LLC

104.87K

-7.47%

BlackRock Institutional Trust Company, N.A.

90.35K

-0.45%

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Fonar Corp is 3.60, ranking 120 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.96. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Fonar Corp’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.